Wottawa A, Klein G, Altmann H. A method for the isolation on human and animal lymphocytes with Ficoll-Urografin. Wien Klin Wochenschr. 1974;86:161-3.

Peper RJ, Zee TW, Mickelson MM. Purification of lymphocytes and platelets by gradient centrifugation. J Lab Clin Med.. 1968;72:842-8.

Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg.. 2000;120:999-1005.

Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg.. 2003;75:204-9.

Higashi Y, Kimura M, Hara K. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation. 2004;109:1215-8.

Carmeliet P. Angiogenesis in health and disease. Nat Med.. 2003;9:653-60.

de Muinck ED, Simons M. Re-evaluating therapeutic neovascularization. J Mol Cell Cardiol.. 2004;36:25-32.

Asahara T, Masuda H, Takahashi T. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res.. 1999;85:221-8.

Simons M. Angiogenesis where do we stand now?. Circulation. 2005;111:1556-66.

Olivares E, Ribeiro VP, Werneck JPS. Cellular cardiomyoplasty with bone marrow cells improves cardiac performance in heart failure induced by healed infarct in rats. J Am Coll Cardiol.. 2003;41:181A.

Dohmann HFR, Perin EC, Borojevic R. Melhora sintomática e da capacidade de exercício após transplante autólogo, transendocárdico, de células mononucleares da medula óssea em pacientes com cardiopatia isquêmica grave, sustentada até o sexto mês de evolução. Arq Bras Cardiol.. 2005;84:360-6.

Orlic D, Kajstura J, Chimenti S. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-5.

Asahara T, Murohara T, Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-7.

Bishop ET, Bell GT, Bloor S, Broom IJ, Hendry NF, Wheatley DN. An in vitro model of angiogenesis: basic features. Angiogenesis. 1999;3:335-44.

Tamarat R, Silvestre JS, Kubis N. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension. 2002;39:830-5.

Iba O, Matsubara H, Nozawa Y. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation. 2002;106:2019-25.

Shintani S, Murohara T, Ikeda H. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation. 2001;103:897-903.

Tateishi-Yuyama E, Matsubara H, Murohara T. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of marrow cells: a pilot study and randomised, controlled trial. Lancet. 2002;360:427-35.

Kawamura A, Horie T, Tsuda I. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther Apher Dial. 2005;9:59-63.

Huang PP, Li SZ, Han MZ. Transplantation of autologous peripheral blood cells for the treatment of lower limb arteriosclerosis obliterans. Zhonghua Xue Ye Xue Za Zhi. 2003;24:308-11.

Yang XF, Wu YX, Wang HM. Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder. Zhonghua Nei Ke Za Zhi. 2005;44:95-8.

Huang PP, Li SZ, Han MZ. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haemost.. 2004;91:606-9.

Hernández Ramirez P, Dorticós Balea E, Hernández Padron C. Trasplante de células madre autólogas en el miembro inferior isquémico de un paciente con arteriosclerosis obliterante crítica. Rev Cubana Hematol Inmunol Hemoter.. 2005;21:33-8.